AzTrials
AzTrials

StrokeNCT04376138

Longitudinal Validation of Neurofeedback in Stroke Motor Rehabilitation Through Brain Imaging

A study testing BCI intervention and Conventional Therapy in people with Stroke, run by Universidade da Madeira at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the main goal of generalising findings into Virtual Reality-Neurofeedback-Motor imagery (VR-NF-MI) system, this project aims to develop a new motor rehabilitation tool, for the upper limb, allied to the use of rising of information and communication technologies (ICT). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
BCI intervention and Conventional Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 sitePortugal
Study dates
17 Aug 2019to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First stroke episode
  • More than six months after stroke
  • Stroke hemiplegia/hemiparesis, (Fugl Meyer below or equal to 47)
  • Capacity to understand and complete simple tasks
  • Know how to read and write
  • Motivation to participate

Who cannot join

  • Hemi spatial neglect
  • Depressive symptoms, moderate to severe
  • Presence of other neurological or orthopaedic problems
  • Severe eyesight problems
  • Claustrophobia
  • Presence of ferromagnetic materials

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Serviço de Saúde da Região Autónoma da Madeira

    Funchal, Madeira, 9004-514

Other trials in Portugal

About this study

With the main goal of generalising findings into Virtual Reality-Neurofeedback-Motor imagery (VR-NF-MI) system, this project aims to develop a new motor rehabilitation tool, for the upper limb, allied to the use of rising of information and communication technologies (ICT). By identifying correlations on the neural activity, during motor imagery and through brain imaging (fMRI), with distinct training protocols and feedback, these protocols are developed to create user-specific models that later can be used in NF-MI rehabilitation sessions.

Read the detailed description

Every year millions of people worldwide suffer from stroke, being one of the leading causes of death and longterm disability. This leads to cognitive and motor impairments, resulting in loss of independence in their daily life together with an additional psychological impact in mood disorders and depression. Evolving to a chronic condition, stroke requires continuous rehabilitation and therapy. Personalised Virtual-Reality (VR) approaches have been shown to accelerate the recovery process compared to non-Information and communication technologies (ICT) based interventions. However, most of these novel VR approaches are suitable only for a reduced subset of patients, generally those with better recovery prognostics and better motor control. Thus, the idea of training the central nervous system was established, through EEG-based neurofeedback (NF) and motor-imagery (MI). Although the benefits of MI-NF have been illustrated in a plethora of studies, the reduced ability for stroke patients to use NF does not allow an accurate control, reducing the capabilities of MI-NF systems. The aim of this project is to develop a novel and more inclusive rehabilitation system with the use of novel ICT technologies, in order to overcome current limitations. This will be achieved by identifying the neural correlates of motor action during motor imagery through brain imaging (fMRI), and differences in brain activation with different training feedback protocols for formulating user-specific models that will be used later in NF-MI rehabilitation sessions. This will facilitate the use of neural interfaces to train the central nervous system; specifically, the investigators will develop a personalized EEG-based immersive NF through VR for MI training. The ultimate goal is to generalize the findings into a VR-NF-MI training paradigm for both admitted and ambulatory patients as well as continued domestic care.

Conditions
Stroke
Being tested
BCI intervention, Conventional Therapy
Keywords
Brain Computer Interface, Virtual Reality, Stroke rehabilitation, Electroencephalography, Motor Imagery
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BCI interventionOther

    Also called Brain Computer Interaction (BCI) and neurofeedback for stroke rehabilitation

    30 minutes intervention that occurs 3 times per week, with a goal of 12 sessions total.

  • Conventional TherapyOther

    Also called Traditional motor rehabilitation for the upper limb

    30 minutes intervention that occurs 3 times per week, with a goal of 12 sessions total.

Study groups in NCT04376138
Study groupRoleWhat they receive
Motor ImageryExperimentalA Brain-Computer Interaction (BCI) based intervention while receiving conventional therapy. Use of motor imagery training, allied with brain-computer interaction, as a solution to promote motor and cognitive gains in stroke survivors.
Receives: Other: BCI intervention
Conventional TherapyActive comparatorExtra Occupational Therapy sessions while receiving conventional therapy. Use of conventional therapy techniques and tools for motor rehabilitation, following the original therapeutic intervention plan of the participants.
Receives: Other: Conventional Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from the baseline in the functional magnetic resonance imaging (fMRI)

    Analyze cortical activation, during motor imagery exercises, and cortical structure.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

  2. Change from the baseline in the Fugl Meyer Motor Assessment

    Evaluates the motor function of the affected upper limb. This section has a maximum score of 66 and changes to a higher score means an evolution on motor recovery.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

Secondary outcomes (5)
  1. Change from the baseline in the electroencephalography (EEG) data

    Analyze brain activity during motor imagery training to identify the best EEG features that better correlate with the brain activity in motor areas of each participant using Common Spatial Pattern filters. Examine different modulation rhythms focusing on Alpha and Beta rhythms, during Motor imagery for each BCI session, aiming to find changes in brain activity, in motor and cognitive areas that are related to motor imagery. Some feature candidates are, Power, Connectivity and Event-Related Synchronization/Desynchronization (ERS/ERD) maps.

    Measured: In all 12 sessions for 4 weeks

  2. Change from the baseline in the Kinesthetic and Visual Imagery Questionnaire (KVIQ)

    Assess the motor imagery capacity of the stroke participants. The maximum score is 100 and a high score reflects a greater ability to visualize and feel imaginary movements.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

  3. Change from the baseline in the Montreal Cognitive Assessment (MoCA)

    The screening test used to assess different cognitive domains. The test has a total of 30 points; the higher the score the lesser the probability of cognitive impairment.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

  4. Change from the baseline in the Modified Ashworth Scale (MAS)

    Assess muscle tone during movement, in the elbow joint. The score is valued from 0 to 4 (0, 1, 1+, 2, 3 and 4), a higher score is related to higher spasticity and muscle tone.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

  5. Change from the baseline in the Geriatric Depression Scale (GDS)

    Self-report assessment to measure depression symptoms in the elderly. It has a maximum score of 30 points where a score superior to 21 is indicative of the presence of severe depression. From 11 to 20 points is indicative of mild depression and a score equal or inferior to 10, to the absence of depression.

    Measured: Baseline, Final (4 weeks) and 1 month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2020
  2. Study start17 Aug 2019
  3. Primary completion30 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04376138
Sponsor's protocol ID
031485
Status last verified
Dec 2024
First submitted
16 Apr 2020
Last updated
13 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing BCI intervention and Conventional Therapy in people with Stroke, run by Universidade da Madeira at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from the baseline in the functional magnetic resonance imaging (fMRI) (time frame: Baseline, Final (4 weeks) and 1 month follow up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in